SH, H. A. A., M, A., MZ, H., M, I., Z, Z., & MN, H. (2012). Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite. Dove Medical Press.
Cita Chicago Style (17a ed.)SH, Hussein Al Ali, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, y Hakim MN. Controlled Release and Angiotensin-converting Enzyme Inhibition Properties of an Antihypertensive Drug Based on a Perindopril Erbumine-layered Double Hydroxide Nanocomposite. Dove Medical Press, 2012.
Cita MLA (8a ed.)SH, Hussein Al Ali, et al. Controlled Release and Angiotensin-converting Enzyme Inhibition Properties of an Antihypertensive Drug Based on a Perindopril Erbumine-layered Double Hydroxide Nanocomposite. Dove Medical Press, 2012.